An inverse relationship was also observed in recent clinical studies between circulating omentin levels and surrogate makers of cardiovascular risk, including arterial stiffness [6], endothelial dysfunction [12], carotid intima-media thickness (IMT) [13, 14], and carotid plaque instability [15]. The gene discussed is ITLN1; the disease is endothelial dysfunction.